| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.4 | 1e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.37 | 2e-09 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.32 | 2e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 3e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 6e-05 |